Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 85

1.

Cervical spinal cord atrophy: An early marker of progressive MS onset.

Zeydan B, Gu X, Atkinson EJ, Keegan BM, Weinshenker BG, Tillema JM, Pelletier D, Azevedo CJ, Lebrun-Frenay C, Siva A, Okuda DT, Kantarci K, Kantarci OH.

Neurol Neuroimmunol Neuroinflamm. 2018 Jan 22;5(2):e435. doi: 10.1212/NXI.0000000000000435. eCollection 2018 Mar.

2.

Evaluation of idiopathic transverse myelitis revealing specific myelopathy diagnoses.

Zalewski NL, Flanagan EP, Keegan BM.

Neurology. 2018 Jan 9;90(2):e96-e102. doi: 10.1212/WNL.0000000000004796. Epub 2017 Dec 15.

PMID:
29247071
3.

Reply: A case of CLIPPERS challenging the new diagnostic criteria.

Tobin WO, Guo Y, Krecke KN, Keegan BM.

Brain. 2018 Feb 1;141(2):e13. doi: 10.1093/brain/awx336. No abstract available.

PMID:
29244097
4.

Reply: CLIPPERS, a possible symptomatic lymphohistiocytic immune reaction.

Tobin WO, Guo Y, Keegan BM.

Brain. 2018 Jan 1;141(1):e6. doi: 10.1093/brain/awx299. No abstract available.

PMID:
29161360
5.

Diagnostic criteria for chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS).

Tobin WO, Guo Y, Krecke KN, Parisi JE, Lucchinetti CF, Pittock SJ, Mandrekar J, Dubey D, Debruyne J, Keegan BM.

Brain. 2017 Sep 1;140(9):2415-2425. doi: 10.1093/brain/awx200.

PMID:
29050399
6.

Cannabinoid Receptor Interacting Protein 1a Competition with β-Arrestin for CB1 Receptor Binding Sites.

Blume LC, Patten T, Eldeeb K, Leone-Kabler S, Ilyasov AA, Keegan BM, O'Neal JE, Bass CE, Hantgan RR, Lowther WT, Selley DE, Howlett AL.

Mol Pharmacol. 2017 Feb;91(2):75-86. doi: 10.1124/mol.116.104638. Epub 2016 Nov 28.

7.

Progressive solitary sclerosis: Gradual motor impairment from a single CNS demyelinating lesion.

Keegan BM, Kaufmann TJ, Weinshenker BG, Kantarci OH, Schmalstieg WF, Paz Soldan MM, Flanagan EP.

Neurology. 2016 Oct 18;87(16):1713-1719. Epub 2016 Sep 16.

8.

Diagnostic Value of Brain Calcifications in Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia.

Konno T, Broderick DF, Mezaki N, Isami A, Kaneda D, Tashiro Y, Tokutake T, Keegan BM, Woodruff BK, Miura T, Nozaki H, Nishizawa M, Onodera O, Wszolek ZK, Ikeuchi T.

AJNR Am J Neuroradiol. 2017 Jan;38(1):77-83. doi: 10.3174/ajnr.A4938. Epub 2016 Sep 15.

9.

The contemporary spectrum of multiple sclerosis misdiagnosis: A multicenter study.

Solomon AJ, Bourdette DN, Cross AH, Applebee A, Skidd PM, Howard DB, Spain RI, Cameron MH, Kim E, Mass MK, Yadav V, Whitham RH, Longbrake EE, Naismith RT, Wu GF, Parks BJ, Wingerchuk DM, Rabin BL, Toledano M, Tobin WO, Kantarci OH, Carter JL, Keegan BM, Weinshenker BG.

Neurology. 2016 Sep 27;87(13):1393-9. doi: 10.1212/WNL.0000000000003152. Epub 2016 Aug 31.

10.

Serial cerebrospinal fluid examinations to diagnose hematological malignancy causing neurological disease.

Scharf EL, Hanson CA, Howard MT, Keegan BM.

J Neurooncol. 2016 Aug;129(1):77-83. doi: 10.1007/s11060-016-2140-y. Epub 2016 May 9.

PMID:
27161251
11.

Discriminating long myelitis of neuromyelitis optica from sarcoidosis.

Flanagan EP, Kaufmann TJ, Krecke KN, Aksamit AJ, Pittock SJ, Keegan BM, Giannini C, Weinshenker BG.

Ann Neurol. 2016 Mar;79(3):437-47. doi: 10.1002/ana.24582. Epub 2016 Feb 12.

PMID:
26677112
12.

Diagnostic Yield and Safety of Cerebellar and Brainstem Parenchymal Biopsy.

Tobin WO, Meyer FB, Keegan BM.

World Neurosurg. 2015 Dec;84(6):1973-6. doi: 10.1016/j.wneu.2015.08.062. Epub 2015 Sep 2.

PMID:
26342777
13.

Poor early relapse recovery affects onset of progressive disease course in multiple sclerosis.

Novotna M, Paz Soldán MM, Abou Zeid N, Kale N, Tutuncu M, Crusan DJ, Atkinson EJ, Siva A, Keegan BM, Pirko I, Pittock SJ, Lucchinetti CF, Noseworthy JH, Weinshenker BG, Rodriguez M, Kantarci OH.

Neurology. 2015 Aug 25;85(8):722-9. doi: 10.1212/WNL.0000000000001856. Epub 2015 Jul 24. Erratum in: Neurology. 2015 Oct 13;85(15):1355.

14.

Conjunctival biopsy to diagnose neurosarcoidosis in patients with inflammatory nervous system disease of unknown etiology.

Pichler MR, Flanagan EP, Aksamit AJ, Leavitt JA, Salomão DR, Keegan BM.

Neurol Clin Pract. 2015 Jun;5(3):216-223. doi: 10.1212/CPJ.0000000000000133.

15.

Chronic baclofen desensitizes GABA(B)-mediated G-protein activation and stimulates phosphorylation of kinases in mesocorticolimbic rat brain.

Keegan BM, Beveridge TJ, Pezor JJ, Xiao R, Sexton T, Childers SR, Howlett AC.

Neuropharmacology. 2015 Aug;95:492-502. doi: 10.1016/j.neuropharm.2015.02.021. Epub 2015 Feb 25.

16.

Relapses and disability accumulation in progressive multiple sclerosis.

Paz Soldán MM, Novotna M, Abou Zeid N, Kale N, Tutuncu M, Crusan DJ, Atkinson EJ, Siva A, Keegan BM, Pirko I, Pittock SJ, Lucchinetti CF, Weinshenker BG, Rodriguez M, Kantarci OH.

Neurology. 2015 Jan 6;84(1):81-8. doi: 10.1212/WNL.0000000000001094. Epub 2014 Nov 14.

17.

Dementia in MS complicated by coexistent Alzheimer disease: Diagnosis premortem and postmortem.

Flanagan EP, Knopman DS, Keegan BM.

Neurol Clin Pract. 2014 Jun;4(3):226-230.

18.

In reply--Sensitivity of [18F]-fluorodeoxyglucose-positron emission tomography in patients with active myelopathy.

Keegan BM, Flanagan EP.

Mayo Clin Proc. 2014 Jun;89(6):859. doi: 10.1016/j.mayocp.2014.03.009. No abstract available.

PMID:
24943702
19.

Specific pattern of gadolinium enhancement in spondylotic myelopathy.

Flanagan EP, Krecke KN, Marsh RW, Giannini C, Keegan BM, Weinshenker BG.

Ann Neurol. 2014 Jul;76(1):54-65. doi: 10.1002/ana.24184. Epub 2014 Jun 14.

PMID:
24838831
20.

Radiologically isolated syndrome: 5-year risk for an initial clinical event.

Okuda DT, Siva A, Kantarci O, Inglese M, Katz I, Tutuncu M, Keegan BM, Donlon S, Hua le H, Vidal-Jordana A, Montalban X, Rovira A, Tintoré M, Amato MP, Brochet B, de Seze J, Brassat D, Vermersch P, De Stefano N, Sormani MP, Pelletier D, Lebrun C; Radiologically Isolated Syndrome Consortium (RISC); Club Francophone de la Sclérose en Plaques (CFSEP).

PLoS One. 2014 Mar 5;9(3):e90509. doi: 10.1371/journal.pone.0090509. eCollection 2014.

21.

[(18)F]-fluorodeoxyglucose-positron emission tomography in patients with active myelopathy.

Flanagan EP, Hunt CH, Lowe V, Mandrekar J, Pittock SJ, O'Neill BP, Keegan BM.

Mayo Clin Proc. 2013 Nov;88(11):1204-12. doi: 10.1016/j.mayocp.2013.07.019.

PMID:
24182701
22.

Amyloid-β-related angiitis presenting as a uveomeningeal syndrome.

Child ND, Braksick SA, Flanagan EP, Keegan BM, Giannini C, Kantarci OH.

Neurology. 2013 Nov 12;81(20):1796-8. doi: 10.1212/01.wnl.0000435560.00234.a7. Epub 2013 Oct 16.

PMID:
24132378
23.

Therapeutic decision making in a new drug era in multiple sclerosis.

Keegan BM.

Semin Neurol. 2013 Feb;33(1):5-12. doi: 10.1055/s-0033-1345709. Epub 2013 May 25. Review.

PMID:
23709208
24.

Current and emerging therapies for multiple sclerosis.

Keegan BM.

Semin Neurol. 2013 Feb;33(1):3. doi: 10.1055/s-0033-1345711. Epub 2013 May 25. No abstract available.

PMID:
23709207
25.

Sjogren's syndrome with trigeminal neuropathy: motor involvement.

Flanagan EP, Kaufmann TJ, Keegan BM.

Pract Neurol. 2013 Oct;13(5):340-2. doi: 10.1136/practneurol-2013-000560. Epub 2013 May 23. No abstract available.

PMID:
23703941
26.

Paraneoplastic myelopathy.

Flanagan EP, Keegan BM.

Neurol Clin. 2013 Feb;31(1):307-18. doi: 10.1016/j.ncl.2012.09.001. Review.

PMID:
23186906
27.

Cutting-edge questions about CLIPPERS (chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids).

Keegan BM, Pittock SJ.

Arch Neurol. 2012 Jul;69(7):819-20. doi: 10.1001/archneurol.2012.1015. No abstract available.

PMID:
22777258
28.

Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis.

Tutuncu M, Tang J, Zeid NA, Kale N, Crusan DJ, Atkinson EJ, Siva A, Pittock SJ, Pirko I, Keegan BM, Lucchinetti CF, Noseworthy JH, Rodriguez M, Weinshenker BG, Kantarci OH.

Mult Scler. 2013 Feb;19(2):188-98. doi: 10.1177/1352458512451510. Epub 2012 Jun 26.

29.

Outcomes after percutaneous surgery for patients with multiple sclerosis-related trigeminal neuralgia.

Mallory GW, Atkinson JL, Stien KJ, Keegan BM, Pollock BE.

Neurosurgery. 2012 Sep;71(3):581-6; discussion 586. doi: 10.1227/NEU.0b013e31825e795b.

PMID:
22592326
30.

A case of necrotizing myopathy with proximal weakness and cardiomyopathy.

Matthews E, Plotz PH, Portaro S, Parton M, Elliott P, Humbel RL, Holton JL, Keegan BM, Hanna MG.

Neurology. 2012 May 8;78(19):1527-32. doi: 10.1212/WNL.0b013e3182553baa. No abstract available.

PMID:
22565568
31.

A 21-year-old woman with multiple cancers and a new brain lesion.

Schiff D, Lam EM, Parisi JE, Giannini C, Uhm JH, Keegan BM, Kantarci OH.

Neurology. 2012 Mar 6;78(10):743-9. doi: 10.1212/WNL.0b013e318248e59c. No abstract available.

PMID:
22391604
32.

Progressive multifocal leukoencephalopathy in a patient treated with etanercept.

Graff-Radford J, Robinson MT, Warsame RM, Matteson EL, Eggers SD, Keegan BM.

Neurologist. 2012 Mar;18(2):85-7. doi: 10.1097/NRL.0b013e318247b868.

PMID:
22367837
33.

Solitary sclerosis: progressive myelopathy from solitary demyelinating lesion.

Schmalstieg WF, Keegan BM, Weinshenker BG.

Neurology. 2012 Feb 21;78(8):540-4. doi: 10.1212/WNL.0b013e318247cc8c. Epub 2012 Feb 8.

PMID:
22323754
34.

Secondary intramedullary spinal cord non-Hodgkin's lymphoma.

Flanagan EP, O'Neill BP, Habermann TM, Porter AB, Keegan BM.

J Neurooncol. 2012 May;107(3):575-80. doi: 10.1007/s11060-011-0781-4. Epub 2011 Dec 22.

PMID:
22189600
35.

An enhancing brainstem lesion in a patient with a history of worldwide travel.

Roos KL, Gerdes LA, Kurz K, Kretzschmar H, Kümpfel T, Parisi JE, Keegan BM.

Neurology. 2011 Nov 8;77(19):1756-60. doi: 10.1212/WNL.0b013e318236eec2. No abstract available.

PMID:
22067962
36.

Evidence for the role of B cells and immunoglobulins in the pathogenesis of multiple sclerosis.

Wootla B, Denic A, Keegan BM, Winters JL, Astapenko D, Warrington AE, Bieber AJ, Rodriguez M.

Neurol Res Int. 2011;2011:780712. doi: 10.1155/2011/780712. Epub 2011 Sep 22.

37.

Primary intramedullary spinal cord lymphoma.

Flanagan EP, O'Neill BP, Porter AB, Lanzino G, Haberman TM, Keegan BM.

Neurology. 2011 Aug 23;77(8):784-91. doi: 10.1212/WNL.0b013e31822b00b9. Epub 2011 Aug 10.

PMID:
21832220
38.

A middle-aged woman with nausea, weight loss, and orthostatic hypotension.

Singer W, Yung IO, Wollmann R, Kelly T, Keegan BM.

Neurology. 2011 Aug 2;77(5):489-95. doi: 10.1212/WNL.0b013e318227b18a. No abstract available.

PMID:
21810698
39.

Natalizumab for multiple sclerosis: a complicated treatment.

Keegan BM.

Lancet Neurol. 2011 Aug;10(8):677-8. doi: 10.1016/S1474-4422(11)70150-8. No abstract available.

PMID:
21777819
40.

Paraneoplastic isolated myelopathy: clinical course and neuroimaging clues.

Flanagan EP, McKeon A, Lennon VA, Kearns J, Weinshenker BG, Krecke KN, Matiello M, Keegan BM, Mokri B, Aksamit AJ, Pittock SJ.

Neurology. 2011 Jun 14;76(24):2089-95. doi: 10.1212/WNL.0b013e31821f468f. Review.

PMID:
21670438
41.

Acquired progressive ataxia and palatal tremor: importance of MRI evidence of hemosiderin deposition and vascular malformations.

Kumar N, Eggers SD, Milone M, Keegan BM.

Parkinsonism Relat Disord. 2011 Aug;17(7):565-8. doi: 10.1016/j.parkreldis.2011.04.018. Epub 2011 May 24.

PMID:
21602091
42.

Beneficial plasma exchange response in central nervous system inflammatory demyelination.

Magaña SM, Keegan BM, Weinshenker BG, Erickson BJ, Pittock SJ, Lennon VA, Rodriguez M, Thomsen K, Weigand S, Mandrekar J, Linbo L, Lucchinetti CF.

Arch Neurol. 2011 Jul;68(7):870-8. doi: 10.1001/archneurol.2011.34. Epub 2011 Mar 14.

43.

A 49-year-old woman with progressive shortness of breath.

Amato AA, Leep Hunderfund AN, Selcen D, Keegan BM.

Neurology. 2011 Mar 1;76(9):830-6. doi: 10.1212/WNL.0b013e31820e7c0d. No abstract available.

PMID:
21357835
44.

Intravascular lymphoma presenting as a longitudinally-extensive myelitis: diagnostic challenges and etiologic clues.

Kumar N, Keegan BM, Rodriguez FJ, Hammack JE, Kantarci OH.

J Neurol Sci. 2011 Apr 15;303(1-2):146-9. doi: 10.1016/j.jns.2010.12.016. Epub 2011 Jan 17.

PMID:
21247588
45.

A case of endocrinologic crisis in a woman with subacute blindness.

Burrus TM, Drake MT, Sanderson SO, Keegan BM.

Neurology. 2010 Nov 2;75(18 Suppl 1):S65. doi: 10.1212/WNL.0b013e3181fb35c6. No abstract available.

PMID:
21041775
46.

Paraneoplastic jaw dystonia and laryngospasm with antineuronal nuclear autoantibody type 2 (anti-Ri).

Pittock SJ, Parisi JE, McKeon A, Roemer SF, Lucchinetti CF, Tan KM, Keegan BM, Hunter SF, Duncan PR, Baehring JM, Matsumoto JY, Lennon VA.

Arch Neurol. 2010 Sep;67(9):1109-15. doi: 10.1001/archneurol.2010.209.

PMID:
20837856
47.

Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS).

Pittock SJ, Debruyne J, Krecke KN, Giannini C, van den Ameele J, De Herdt V, McKeon A, Fealey RD, Weinshenker BG, Aksamit AJ, Krueger BR, Shuster EA, Keegan BM.

Brain. 2010 Sep;133(9):2626-34. doi: 10.1093/brain/awq164. Epub 2010 Jul 17.

PMID:
20639547
48.

Sporadic leucodystrophy with neuroaxonal spheroids: persistence of DWI changes and neurocognitive profiles: a case study.

Mateen FJ, Keegan BM, Krecke K, Parisi JE, Trenerry MR, Pittock SJ.

J Neurol Neurosurg Psychiatry. 2010 Jun;81(6):619-22. doi: 10.1136/jnnp.2008.169243. Epub 2010 Feb 22.

PMID:
20176606
49.

A 74-year-old woman with progressive right-hand tremor and inability to use her right side.

Kertesz A, Fealey RD, Keegan BM, Parisi JE.

Neurology. 2009 Oct 27;73(17):1399-405. doi: 10.1212/WNL.0b013e3181bd80fe. No abstract available.

PMID:
19858463
50.

Atypical acute hemorrhagic leukoencephalitis (Hurst's disease) presenting with focal hemorrhagic brainstem lesion.

Abou Zeid NE, Burns JD, Wijdicks EF, Giannini C, Keegan BM.

Neurocrit Care. 2010 Feb;12(1):95-7. doi: 10.1007/s12028-009-9293-x.

PMID:
19847676

Supplemental Content

Loading ...
Support Center